首页 › 基金 › Artia Global Partners LP › CORT
Artia Global Partners LP 对 CORT 的持仓历史
CORCEPT THERAPEUTICS INC · 医疗保健
Artia Global Partners LP 在 Q3 2026 的 13F 申报中披露持有 CORT(CORCEPT THERAPEUTICS INC)18,000 股,市值约 US$2.1M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 40 位。 Artia Global Partners LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Artia Global Partners LP 对 CORT 的持仓演变
Artia Global Partners LP 于 Q3 2026 首次披露 CORT 持仓:18,000 股(约 US$2.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 18.00K | $2.07M | 新进 |
关于 CORT 与 13F 数据
CORT(CORCEPT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 CORT,申报仓位最大的包括:文艺复兴科技 (US$558.9M), Parallel Advisors, LLC (US$449.7M), TANG CAPITAL MANAGEMENT LLC (US$130.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CORT 的基金
- 文艺复兴科技 4.85M 股 · $558.88M · Q3 2026
- Parallel Advisors, LLC 3.90M 股 · $449.69M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M 股 · $130.43M · Q2 2026
- EMERALD ADVISERS, LLC 758.26K 股 · $87.37M · Q3 2026
- MPM BioImpact LLC 771.03K 股 · $67.04M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 473.88K 股 · $54.61M · Q3 2026
- PERCEPTIVE ADVISORS LLC 398.38K 股 · $34.64M · Q2 2026
更多关于 Artia Global Partners LP
常见问题
How long has Artia Global Partners LP held CORT?
Artia Global Partners LP has disclosed CORT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Artia Global Partners LP's current position in CORT?
As of Q3 2026, Artia Global Partners LP holds 18.00K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $2.07M, representing 0.42% of its reported portfolio and ranking #40.
Has Artia Global Partners LP been buying or selling CORT?
In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in CORT.
Which other funds hold CORT?
Other major institutional holders of CORT include 文艺复兴科技, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.